People · Operator
Named in public records as an officer, director or promoter · active 2011–2016 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Mersana Therapeutics Inc | — | Biotechnology | Series B | $93.7M | $1.3B | 2015 |
| Aquinox Pharmaceuticals (Usa) Inc | — | Pharmaceuticals | Series A | $30.6M | $433.6M | 2011 |
ELAINE J. JONES at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside ELAINE J. JONES on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Elaine Jones | 2 | 6 |
| Asish Xavier | 1 | 18 |
| David Mott | 1 | 9 |
| Thomas Beck | 1 | 7 |
| Kenneth Galbraith | 1 | 6 |
| Sara Nayeem | 1 | 4 |
| C. Boyd Clarke | 1 | 4 |
| Daniel Levitt | 1 | 2 |
| Sara G. Nayeem | 1 | 2 |
| David G. Mott | 1 | 2 |
| PETER PARK | 1 | 2 |
| David Main | 1 | 2 |
| SARA J. NAYEEM | 1 | 2 |
| Peter G. Park | 1 | 1 |
| Kamran Alam | 1 | 1 |
| Nicholas G. Bacopoulos | 1 | 1 |
| Thomas Boyd Beck | 1 | 1 |
| Wayne B. Foster | 1 | 1 |
| Martin Boyd Vogelbaum | 1 | 1 |
| Michael G. Metzger | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.